Novelix Pharmaceuticals Ltd

📈 Vupparapalli Pavani Increases Stake in Novelix Pharmaceuticals

• Vupparapalli Pavani, a promoter, acquired 325,000 equity shares via preferential allotment on February 12, 2026

• Her shareholding increased from 400,000 shares (2.27% of voting capital) to 725,000 shares (3.64% of voting capital)

• Company's equity share capital rose from ₹176,150,000 to ₹199,350,000

• Total diluted capital including outstanding convertible warrants is ₹266,850,000